Abstract: The present invention relates to a recombinant microorganism which is modified to be capable of producing diosmetin and/or hesperetin and to the use thereof for producing diosmetin and/or hesperetin.
Type:
Grant
Filed:
February 11, 2020
Date of Patent:
January 7, 2025
Assignee:
ABOLIS BIOTECHNOLOGIES
Inventors:
Cyrille Pauthenier, André Le Jeune, Hélène Scornec, Célia Roussel, Laetitia Joubert